Prostatype Genomics AB
556726-0285ActiveGenomic classifier test guides prostate cancer treatment decisions for patients.
Genomics / Biotechnology Companyprostatype.com
Overview
- 5–9
- Employees
- 200–299K SEK
- Revenue
- 2007
- Founded
Key Decision Makers
Anders Lundberg
Chairman of the Board
Steven Gaal
President
Emelie Berglund
Chief Technology Officer
Gerald Andriole
Chief Medical Officer
+8 more contacts in Funnelfeedr
Description
Prostatype Genomics is a specialized biotechnology company focused on improving outcomes for men diagnosed with localized prostate cancer. They provide the Prostatype® Genomic Classifier (PGC™), a next-generation prognostic test developed from extensive research at the Karolinska Institute. This non...